Search clinical trials for: Dosimetry

Total 204 results

University of Magdeburg
Sirtex Medical

Completed

Preventive Effect of Enoxaparin, Pentoxifylline and Ursodeoxycholic Acid to Radiation Induced Liver Toxicity (ELDORADO)

Colorectal Cancer | Liver Metastases | Irradiation Damage | Radiation Induced Liver Disease

Germany
AHS Cancer Control Alberta

Withdrawn

A Radiopharmacokinetic and Radiodosimetric Phase I Imaging Study of 18F-FAZA

Hypoxic Tumours
St. Louis University

Withdrawn

Changes in Central Arterial Pressure When Comparing ACOG Hypertensive Urgency Protocols

Hypertension
University of Florida
Baylor College of Medicine

Completed

Radioactive Iodide Therapy for Pediatric Graves' Disease

Graves' Disease

United States
Cancer Targeted Technology
University of California, San Francisco

Completed

A Phase 1 Trial for Evaluation of the Safety, Pharmacokinetics, and [18F] Radiation Dosimetry of CTT1057

Prostate Cancer

United States
Stanford University

Terminated

Pilot Study to Determine Radioiodide Accumulation and Dosimetry in Breast Cancers Using 124I PET/CT

Breast Cancer | Breast Cancer Early Stage Breast Cancer (Stage 1-3) | Breast Cancer Metastatic Breast Cancer

United States
University of Nove de Julho
Sandra Kalil Bussadori

Completed

Dose Parameters for Photodynamic Therapy on Periodontal Disease

Chronic Periodontitis
Sue O'Dorisio
National Cancer Institute (NCI); National Institutes of Health (NIH)

Withdrawn

Dosimetry Guided PRRT With 90Y-DOTATOC

Medulloblastoma | Neuroblastoma | Meningioma | Neuroendrocrine Tumors
Biotie Therapies Inc.
PRA Health Sciences; Tandem Labs; Xceleron Inc

Completed

Study to Evaluate the Absorption, Distribution, Break Down and Elimination and the Safety of 14C-Labeled Tozadenant

N/A, as Healthy Volunteers

Netherlands
Peregrine Pharmaceuticals

Terminated

Open-label, Single Arm, Tumor Imaging and Dosimetry Study of I-124 PGN650 in Advanced Solid Tumors

Malignant Solid Tumor

United States
GlaxoSmithKline

Completed

A Study Of Pharmacokinetics, Whole Body And Organ Dosimetry, And Biodistribution Of Fission-Derived Iodine I 131 Tositumomab (BEXXAR®) For Patients With Previously Untreated Or Relapsed Follicular Or Transformed Non-Hodgkin's Lymphoma

Lymphoma, Follicular
National Institute of Mental Health (NIMH)

Completed

PET Whole Body Distribution Studies Using [11C]CUMI

Depression | Anxiety Disorders | Major Depression | Unipolar Depression | Anxiety Disorder

United States
Duke University
Wallace H. Coulter Foundation

Completed

Real Time In-Vivo Dosimetry For Gynecologic Brachytherapy

Cancer of the Cervix, Cancer of the Endometrium

United States
GE Healthcare
Centre for Probe Development and Commercialization

Completed

Assess Safety, Bio-distribution, Radiation Dosimetry and Optimize the Imaging Protocol of GEH120714 (18F) Injection in Healthy Volunteers and Participants With Relapsing and Remitting Multiple Sclerosis (rrMS).

Relapsing-remitting Multiple Sclerosis (rrMS)

Canada
GlaxoSmithKline

Completed

Dosimetry/Validation Study of 131Iodine-Anti B1 (Murine) Radioimmunotherapy for Chemotherapy Refractory Low Grade B Cell Lymphomas and Low Grade Lymphomas That Have Transformed to Higher Grade Histologies (RIT-II-001)

Lymphoma, Non-Hodgkin
Bayer

Completed

Safety, Biodistribution, Radiation Dosimetry and Pharmacokinetics Study of BAY88-8223 in Japanese Patients

Prostatic Neoplasms

Japan
University Hospital, Caen
CNRS, UMR ISTCT 6301, LDM-TEP Groupe, GIP Cyceron, Caen, France

Completed

Dosimetry and Biodistribution of [18F]-Fludarabine in Lymphoid Malignancies (FLUDATEP)

Untreated B-Chronic Lymphocytic Leukemia or Diffuse Large B Cells Lymphoma Patients

France
Molecular Insight Pharmaceuticals, Inc.

Completed

Phase 1 Study of Iobenguane (MIBG) I 131 in Patients With Malignant Pheochromocytoma/Paraganglioma

Pheochromocytoma | Paraganglioma

United States
Gustave Roussy, Cancer Campus, Grand Paris

Terminated

Comparison of Dosimetry After rhTSH or Withdrawal of Thyroid Hormone in Metastatic or Locally Advanced Thyroid Cancer (DOSIMETA)

Thyroid Cancer | Metastases

France
University of Michigan
National Institutes of Health (NIH)

Completed

Imaging Based Dosimetry for Individualized Internal Emitter Therapy

Non-Hodgkin's Lymphoma

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

In Vivo Dosimetry During Prostate Cancer Radiotherapy

Prostate Disease

United States
AHS Cancer Control Alberta

Completed

Image and Dosimetry Related Research of Department of Medical Physics, Cross Cancer Institute

Healthy

Canada
Lund University Hospital
Bayer

Completed

High Dose, Absorbed Dose Adjusted 90Y-ibritumomab With Peripheral Blood Stem Cells (PBSC) Support in B-cell Lymphoma (HITT)

B-cell Lymphoma

Sweden
Merck Sharp & Dohme LLC

Completed

Safety, Radiation Dosimetry, Biokinetics, and Effectiveness of [18F]MK3328 (MK-3328-001)

Alzheimer's Disease
University College, London
University College London Hospitals

Unknown

Gamma Knife Dosimetric Differences, TMR 10 Versus Convolution Algorithm

Gamma Knife Radiosurgery

United Kingdom
National University Hospital, Singapore
Changi General Hospital; National Heart Centre Singapore; Singapore Clinical...

Unknown

Nitrates In Combination With Hydralazine in cardiorEnal Syndrome (NICHE) Study (NICHE)

Cardio-Renal Syndrome

Singapore
Bayer

Completed

Evaluation of ZK 6032924 in Probable Alzheimer's Disease Patients Versus Healthy Volunteers and the Radiation Dosimetry of ZK 6032924 in Healthy Volunteers

Alzheimer's Disease | Positron-Emission Tomography

Netherlands, Sweden
Xijing Hospital

Unknown

68Ga-NOTA-NFB: Radiation Dosimetry in Healthy Volunteers and Applications in Glioma Patients or Breast Cancer Patients (GNNGB)

Glioma | Breast Cancer

China
Life Molecular Imaging SA

Completed

Radiation Dosimetry, Metabolism, Pharmacokinetics, Safety and Tolerability and PET Imaging With BAY94-9392 in Healthy Volunteers and Patients With Cancer or Inflammation

Neoplasms | Diagnostic Imaging

Korea, Republic of, United States, Germany
SeeCure LLC

Unknown

The Study of Biodistribution and Dosimetry of 99mTc-Glycopeptide(99mTc-GP) in Patients With Breast Cancer

Breast Cancer

United States
Bayer

Terminated

Positron Emission Tomography/Computed Tomography (PET/CT) Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86-4367 in Patients With Prostate Cancer and Healthy Volunteers

Diagnostic Imaging

Switzerland, Germany
Bayer

Completed

Alpharadin™ (Radium-223 Chloride) Safety and Dosimetry With HRPC That Has Metastasized to the Skeleton

Prostate Cancer | Pharmacokinetics | Metastases

United States
Bayer

Completed

Evaluation of the Neuroinflammation Pattern of BAY85-8102 F-18, DPA-714 in Probable Alzheimers Disease Patients Versus Healthy Volunteers and Radiation Dosimetry of F 18, DPA-714 in Healthy Volunteers

Diagnostic Imaging

Finland, Netherlands
BioMed Valley Discoveries, Inc

Completed

Biodistribution and Dosimetry Evaluation of [124I]FIAU

Prosthesis Related Infections

United States
Fluoropharma, Inc.

Completed

A Phase I Study in Healthy Volunteers to Evaluate the Safety of CardioPET™ in Detection of Coronary Artery Disease

Coronary Artery Disease

United States
Fluoropharma, Inc.

Completed

A Phase I Study to Evaluate BFPET as a Potential Myocardial Perfusion Imaging(MPI) Agent for PET

Coronary Artery Disease

United States
Cell>Point LLC
Venn Life Sciences; Biomedical Systems; Numoda; Camargo Pharmaceutical Services

Completed

Pharmacokinetic and Radiation Dosimetry Study Evaluating 99m TC-EC-DG SPECT/CT in Patients With Non-small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer

United States
The University of Texas Medical Branch, Galveston

Completed

Radiation Dosimetry Study Comparing 2 Different Patient Setups in Anal/Rectal Cancer Patients

Anal Cancer

United States
Tianjin Medical University General Hospital
Shehzaad Joomye; Haiyun Wang; Donglai Yan

Unknown

Study of Cisatracurium and Sufentanil Consumption Using a Closed Loop Computer Control Infusion System

The Intraoperative Effect of Dexmedetomidine on Cisatracurium Infusion Consumption and Its Recovery Index. | Effect of Dexmedetomidine on Sufentanil Consumption. | Quantitative Analysis of Cisatracurium Infusion Requirements, Sufentanil Consumption and Recovery Index in Different Age...

China
Life Molecular Imaging SA

Completed

PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Safety and Tolerability in Healthy Volunteers and Safety, Tolerability and Diagnostic Performance of BAY86-9596 in Patients With Non-small Cell Lung Cancer, Breast Cancer, Head and Neck Cancer and Patients With Inflammations

Diagnostic Imaging

Netherlands, Switzerland
Life Molecular Imaging SA

Completed

PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Biodistribution, Safety and Tolerability and Diagnostic Performance of BAY86-7548 in Patients With Prostate Cancer and Healthy Volunteers

Diagnostic Imaging

Switzerland, Finland, Germany
Life Molecular Imaging SA

Completed

Evaluation of the Diagnostic Potential of BAY1006578 in Probable Alzheimers Disease Patients Versus Healthy Volunteers and Radiation Dosimetry of BAY1006578 in Healthy Volunteers

Diagnostic Imaging

Sweden, Finland
Bennett Chin
National Cancer Institute (NCI); Molecular Insights Pharmaceuticals

Completed

Phase I Study of the Safety, Distribution, and Radiation Dosimetry of Ultratrace Iobenguane 123I-mIBG (mIBG)

Heart Failure | Neuroendocrine Tumors

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
United States Department of Defense

Completed

Study of Image-guided Dosimetry for Interstitial Prostate Brachytherapy

Locally Confined Adenocarcinoma of the Prostate

United States
Virginia Commonwealth University

Completed

Pilot Study of 18F Fluoropaclitaxel (FPAC)

Breast Cancer

United States
Molecular Insight Pharmaceuticals, Inc.

Completed

ULTRATRACE Iobenguane I 131 in Patients With Malignant Pheochromocytoma, Paraganglioma, or Metastatic Carcinoid

Pheochromocytoma | Paraganglioma | Carcinoid
Molecular Insight Pharmaceuticals, Inc.

Completed

Study to Evaluate the Safety, Pharmacokinetics, Tissue Distribution, Metabolism and Dosimetry of Two Prostate Cancer Imaging Agents

Prostate Cancer

United States
Molecular Insight Pharmaceuticals, Inc.

Terminated

Phase I Safety and Dosimetry Study in Patients With Confirmed Metastatic Melanoma

Metastatic Melanoma

United States
Cellectar, Inc

Completed

Dosimetry Study of I-131-CLR1404 in Patients With Relapsed or Refractory Advanced Solid Tumors

Solid Tumors

United States
University of Rochester

Terminated

Radiation Dosimetry in Teeth

Radiation Tolerance

United States

3

Subscribe